FDA fast-tracks monoclonal antibody to prevent COVID-19 for certain immunocompromised people

People who are immunocompromised have a new tool to prevent COVID-19. On Friday, the Food and Drug Administration approved Pemgarda, a https://www.mcknights.com/news/clinical-news/fda-allows-injections-reduced-dose-of-covid-monoclonal-antibody-therapy/ that’s designed to protect immunocompromised individuals over the [...]